Cecile Bauche

Cecile Bauche

Company: Alaya Bio

Job title: Chief Scientific Officer


From NEXT to NICE: From Nanoparticles-based Ex vivo Therapeutics to Nanoparticles-based In vivo Cell Engineering 3:30 pm

• Hybrid/polymeric nanoparticles as a solution to improve CAR T-cell manufacturing process and CAR T-cell product attributes. • Key performance criteria for an ideal in vivo CAR re-infusable product • Translational hurdles from ex vivo to in vivo CARsRead more

day: Day 1

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.